DoorDash Gets Into Prescription Delivery With Sam's Club Partnership

One of the largest delivery platforms in the U.S., DoorDash is getting into the growing prescription drug delivery business through a partnership with wholesale giant Sam's Club. 

“Our partnership with DoorDash to launch this new service allows us to not only give our members more convenient healthcare options, but also delivers on our commitment to their overall wellness needs,” said John McDowell, vice president of pharmacy operations and divisional merchandise at Sam’s Club, in a statement. 

DoorDash is tapping Drive, its white-label fulfillment platform for merchants, to power the partnership, which emerged specifically to meet shifting consumer expectations amid COVID.

“Businesses have evolved amidst the pandemic to prioritize the safety of their communities and to adapt to new consumer habits, and our goal is to help merchants meet those demands in a way that’s best for their business,” said Christopher Payne, chief operating officer at DoorDash.  

The coronavirus pandemic has accelerated the adoption of prescription drug delivery services. Pharmacies in particular have turned to third parties to compete with online retailers. 

For DoorDash, the partnership comes as the platform teams up with other companies outside of the food category, including PetSmart, Macy's, Walgreens, CVS Pharmacy, and 7-Eleven. 

DoorDash will provide same-day delivery across Sam Club's 500 locations. 

Sam's Club is offering free delivery on their first two pharmacy orders until the end of the year and then charging a flat fee of $7.99 per order.

More In Business

How DC is bringing the box office success of its films to its comics

Movie studios are comfortable digging through comic bins for hot new intellectual property, but they are not comfortable returning the favor and sharing th

The Fed, Big Tech, and What’s Next: Can Markets Find Their Footing?

Chris Versace, CIO at Tematica Research and portfolio manager for TheStreet Pro, joins from the NYSE to break down the Fed’s latest move and Big Tech’s earnings

Politics and the Price of Groceries: Snap Benefits Caught in the Shutdown Crosshairs

Sabrina Siddiqui, National Politics Reporter at The Wall Street Journal, joins to break down the SNAP funding delays and the human cost of the ongoing shutdown.

Conservative Supreme Court justices appear skeptical of tariffs

Arguments at the Supreme Court have concluded for the day as the justices consider President Donald Trump's sweeping unilateral tariffs in a trillion-dollar test of executive power.

Box Office Glow-Up: How Anime Is Outshining Hollywood Hits

Paul Dergarabedian, Senior Media Analyst at Comscore, joins to break down the anime boom at the box office and what it means for the future of film.

The Future of Crime Solving: Longeye’s AI Workspace for Investigators

AI is reshaping investigations. Longeye CEO Guillaume Delepine shares how their AI workspace empowers law enforcement to uncover insights faster and smarter.

From Rates to Rent: Inside the Real Estate Rollercoaster

Frances Katzen, Managing Director at Douglas Elliman, joins to break down shifting housing trends, buyer behavior, and what’s next for real estate.

Getty’s $3.7 billion attempt to buy Shutterstock faces investigation

Britain's antitrust watchdog is intensifying its investigation into Getty Images' plan to buy Shutterstock.

Rate Cut Reaction: Inside the Fed’s 25-Point Move and What Comes Next

Stephen Kates, Financial Analyst at Bankrate, joins to discuss the Fed’s 25-basis-point rate cut, inflation risks, and what it all means for consumers and marke

Inside Big Tech’s Earnings: How Alphabet, Amazon & Microsoft Stack Up

Big tech earnings take center stage as investors digest results from Alphabet, Meta, Microsoft, Amazon, and Apple, with insights from Gil Luria of D.A. Davidson

Load More